Replication of the CANVAS Diabetes Trial in Healthcare Claims

CompletedOBSERVATIONAL

Enrollment

152,202

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions

Diabetes

Interventions

DRUG

Canagliflozin

Canagliflozin dispensing claim is exposure

DRUG

DPP-4 inhibitor

DPP4 inhibitor dispensing claim is reference

Trial Locations (1)

Brigham & Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER

NCT03936010 - Replication of the CANVAS Diabetes Trial in Healthcare Claims | Biotech Hunter | Biotech Hunter